Success Metrics

Clinical Success Rate

88.9%

Based on 8 completed trials

Completion Rate

89%(8/9)

Active Trials

1(8%)

Results Posted

25%(2 trials)

Terminated

1(8%)

Phase Distribution

Ph phase_1

Ph early_phase_1

17%

Ph phase_2

Ph phase_4

58%

Ph not_applicable

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution12 total trials

Early Phase 1First-in-human

2(16.7%)

Phase 1Safety & dosage

1(8.3%)

Phase 2Efficacy & side effects

1(8.3%)

Phase 4Post-market surveillance

7(58.3%)

N/ANon-phased studies

1(8.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(8)

Terminated(1)

Other(2)

Detailed Status

Completed8

unknown2

Recruiting1

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

88.9%

Most Advanced

Phase 4

Trials by Phase

Early Phase 12 (16.7%)

Phase 11 (8.3%)

Phase 21 (8.3%)

Phase 47 (58.3%)

N/A1 (8.3%)

Trials by Status

unknown217%

completed867%

recruiting18%

terminated18%

Recent Activity

1 active trials

Showing 5 of 12

recruitingphase_4

Disentangling the Effects of Daily Stress, Sleep, and Sex Hormones on Accelerated Vascular Aging in Midlife Women

NCT06745466

completedphase_4

Efficacy of Micronized Natural Progesterone vs GnRH Antagonist in the Prevention of LH Peak During Ovarian Stimulation.

NCT05954962

completedearly_phase_1

Clinical Trials (12)

Showing 12 of 12 trials

NCT06745466Phase 4

Disentangling the Effects of Daily Stress, Sleep, and Sex Hormones on Accelerated Vascular Aging in Midlife Women

Recruiting

NCT05954962Phase 4

Efficacy of Micronized Natural Progesterone vs GnRH Antagonist in the Prevention of LH Peak During Ovarian Stimulation.

Completed

NCT04265053Early Phase 1

Human Cerebral Blood Flow Regulation

Completed

NCT01614067Phase 4

Delayed Start to Ovarian Stimulation

Terminated

NCT04654741Phase 4

The Rate of Embryo Euploidy in Progestin-primed Ovarian Stimulation Cycles

Unknown

NCT00589134Not Applicable

The Effects of Estradiol and Progesterone on Arginine Vasopressin Regulation and Serum Sodium Concentration

Completed

NCT03051087Phase 4

To Compare and Evaluate the Efficacy and Safety of Ganilever PFS(Prefilled Syringe) and Orgalutran®

Completed

NCT01153581Phase 2

Sex Hormones and Orthostatic Tolerance

Completed

NCT03477929Phase 4

Cetrorelix and Ganirelix Flexible Protocol for (IVF)

Unknown

NCT00757185Early Phase 1

Compromised Microcirculation in Women With Polycystic Ovary Syndrome

Completed

NCT00225433Phase 4

Luteal Phase FSH in the IVF Poor Responder

Completed

NCT00823004Phase 1

Antagonist/Letrozole in Poor Responders

Completed

All 12 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 12